Novartis India Balance Sheet Annual

Trade

BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | Sector: Biotechnology & Drugs

1,028.20 +2.40 (0.23%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	596.08	15.00	155.00	62.00
Short Term Investments	0.81	535.00	357.94	429.14
Cashand Short Term Investments	596.89	554.42	516.29	497.41
Accounts Receivable- Trade Net	41.47	56.50	115.37	112.31
Total Receivables Net	41.47	59.34	127.56	158.07
Total Inventory	44.86	55.65	58.14	49.59
Other Current Assets Total	16.04	4.93	1.98	15.57
Total Current Assets	699.26	677.29	707.82	723.13
Property/ Plant/ Equipment Total- Net	6.94	19.25	23.65	63.91
Long Term Investments	2.17	0.64	0.82	0.83
Note Receivable- Long Term	123.20	84.44	32.61	29.62
Other Long Term Assets Total	93.36	201.32	192.67	184.80
Total Assets	924.93	982.94	957.57	1,002.29
Accounts Payable	61.59	59.67	72.20	55.20
Notes Payable/ Short Term Debt	0.02	0.00	0.00	0.00
Current Portof LT Debt/ Capital Leases	1.88	4.12	5.74	12.70
Other Currentliabilities Total	93.71	65.19	112.57	65.55
Total Current Liabilities	157.20	159.49	216.42	158.95
Capital Lease Obligations	5.07	17.39	18.27	49.78
Total Long Term Debt	5.07	17.39	18.27	49.78
Total Debt	6.97	21.51	24.01	62.48
Other Liabilities Total	17.84	30.40	31.18	82.37
Total Liabilities	180.11	207.28	265.87	291.10
Common Stock Total	12.34	12.34	12.34	12.34
Retained Earnings( Accumulated Deficit)	732.48	763.36	681.58	701.80
Total Equity	744.82	775.66	691.70	711.19
Total Liabilities Shareholders' Equity	924.93	982.94	957.57	1,002.29
Total Common Shares Outstanding	2.47	2.47	2.47	2.47
Tangible Book Valueper Share Common Eq	301.66	314.15	280.14	288.04
Cash	-	4.42	3.35	6.27
Prepaid Expenses	-	2.95	3.85	2.49
Property/ Plant/ Equipment Total- Gross	-	26.85	32.94	74.81
Accumulated Depreciation Total	-	-7.60	-9.29	-10.90
Accrued Expenses	-	30.51	25.91	25.50
ESOP Debt Guarantee	-	-0.04	-2.22	-2.95